COMPARATIVE EVALUATION OF ALPHA-BLOCKERS IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)

Аннотация

Benign prostatic hyperplasia (BPH) is a common urological condition in aging males, leading to lower urinary tract symptoms (LUTS) that significantly affect quality of life. Alpha-adrenergic blockers are the first-line pharmacological treatment for BPH. This study evaluates and compares the efficacy, tolerability, and side-effect profiles of three commonly used alpha-blockers: tamsulosin, alfuzosin, and silodosin. Our analysis reveals important differences in patient outcomes and provides guidance for individualized therapy.